This topic review will discuss the treatment of men with advanced prostate cancer. A separate topic review is available about the treatment of early stage prostate cancer. (See "Patient information: Early prostate cancer treatment"). STAGING OF PROSTATE CANCER — Treatment for prostate cancer depends upon its "stage", which indicates how far the cancer has spread within the body. Prostate cancer is usually staged according to the system known as TNM (tumor, node, metastasis), in which the cancer is characterized by its extent within the prostate gland itself (tumor or T stage), whether the lymph nodes in the region are involved with cancer (node or N stage), and whether the cancer has metastasized to other parts of the body (metastasis or M stage, show table 1). A full discussion of the diagnosis and staging of prostate cancer is available separately. (See "Patient information: Prostate cancer diagnosis and staging"). Various combinations of T, N, and M stage are grouped together to form stage groupings, from I to IV, which designate whether the cancer is considered localized (stage I and II), locally advanced (stage III), or metastatic (stage IV) (show table 2). T3 and T4 tumors that lack involvement of lymph nodes or distant organs are considered locally advanced, meaning that although the cancer is outside of the prostate gland, it has not extended beyond the tissues adjacent to the original tumor. On the other hand, metastatic (stage IV) prostate cancer has spread beyond the prostate to either the lymph nodes or to other organs or the bone

 Staging in Prostate Cancer
Advanced Prostate Cancer and suggested Treatments
Patient information: Advanced prostate cancer Author Nancy A Dawson, MD Section Editors Nicholas Vogelzang, MD W Robert Lee, MD, MS, MEd Jerome P Richie, MD, FACS Deputy Editors Leah K Mo
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer New Drug Provides Rapid and Sustained Suppression of Testosterone PARSIPPANY,
Increased Risk For Aggressive Prostate Cancer For Men With BRCA Mutations
Increased Risk For Aggressive Prostate Cancer For Men With BRCA Mutations by Jennifer Davis Published 02/18/2009 in Prostate Cancer Men who develop prostate cancer face an increased risk of
New Hope For Men With Advanced Prostate Cancer
New Hope For Men With Advanced Prostate Cancer Reported by: Delaine Mathieu Email: DelaineMathieu@woaitv.com Last Update: 1/22 6:07 pm New Hope For Men With Advanced Prostate Cancer
New Hope For Men With Advanced Prostate Cancer
New Hope For Men With Advanced Prostate Cancer Reported by: Delaine Mathieu Last Update: 1/22 6:07 New Hope For Men With Advanced Prostate Cancer It's new hope for men with advanced
Video Treating Advanced Prostate Cancer
When prostate cancer no longer responds to hormonal therapy, it is called hormone refractory prostate cancer. Learn who's at risk for this stage of disease, and how it's treated. see video at : htt
Video: Quality of Life for the Hormone Refractory Prostate Cancer Patient (HRPC)
see video for treating advanced cancer patients with HRPC http://wrongdiagnosis.healthology.com/hybrid/hybrid-autodetect.aspx?focus_handle=prostate-cancer&Content_ID=3915&brand_name=wrongdiagnosis&